ReviewClinical endoscopy2026
Recent technological advances in device-assisted enteroscopy.
Review in Clinical endoscopy, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Device-assisted enteroscopy (DAE) has revolutionized small bowel evaluation by allowing endoscopic access for both diagnosis and therapy. Since the introduction of double-balloon enteroscopy, newer techniques such as single-balloon enteroscopy, spiral enteroscopy (SE), and balloon-guided systems have expanded clinical options. However, conventional DAE remains limited by procedural complexity, prolonged procedure times, and incomplete enteroscopy. In response, novel technologies have emerged to improve efficiency and outcomes. Among these, motorized power SE (PSE) represents a significant advancement, enabling deeper insertion and single-operator capability. Despite promising early results, PSE has been withdrawn from the market owing to safety concerns, particularly esophageal injuries. Nevertheless, recent studies suggest that PSE may still be a valuable rescue technique in selected cases in which balloon-assisted methods fail. Additional advances, including artificial intelligence-assisted lesion detection, are being integrated into modern DAE platforms. Continued innovation in imaging, device ergonomics, and procedural safety is essential to meet the evolving clinical demands. This review highlights the recent technological progress in DAE and discusses the challenges and future directions for integrating these tools into routine practices.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.